If the ENMD (or any other anti-ang) drugs are successful, wouldn't that put SUPG in an unfavorable competitive position? If the ant-ang drugs are effective what would the market be for SUPG's anti-cancer drugs? Any responses appreciated. Thanks.
seems to me that getting FDA approval is a BIG THING, but the stock is not acting like it....So many shares traded and the stock price is doing nothing, NADA, ,,,,,too bad Im long by 2000 at 15.5 UGH!